MindImmune Therapeutics, Inc. Information
Contact top employees from
MindImmune Therapeutics, Inc.
Summary
MindImmune Therapeutics, Inc. is a private company that has been in the industry for 9 years. The company currently specializes in the Biotechnology area. The position of the President & CEO is occupied by Stevin Zorn. Its headquarters is located at Hartford, Connecticut, USA. The MindImmune Therapeutics, Inc. annual revenue is estimated at < 1M. Total funding of the company - $1M. To connect with MindImmune Therapeutics, Inc. employee register on SignalHire.
Industries
Biotechnology
Headquarters Location
Employees Size
1-10 employees
Specialties
Neuroinflammation, Neuroscience, Neuroimmunology, Pharmaceutical R&D
DMA Code
Greater Hartford
Founded
2016
Operating Status
Independent Company
Employees Turnover 3 quarter 2025
Length of Employment
Employee tenure at MindImmune Therapeutics, Inc. shows a diverse range of experience levels:
14% have been with the company for less than 1 year29% for 1–2 years14% for 3–4 years29% for 5–7 years14% for 8–10 yearsContact top employees from
MindImmune Therapeutics, Inc.
Kenneth Rose
Director of Translational Science
Bob Nelson
Co-Founder | Vice President of Biology
Thomas Prodhomme
Vice President, Preclinical Development
Stevin Zorn
President, CEO, Co-Founder
Frank Menniti
Founder, Chief Science Officer
Joseph Hedde
Research Director
Akriti Srivastava
Senior Scientist
Diane Gooding
Director of Business Operations, and Corporate Treasurer
Katie Dunton
Research Associate
Similar Companies
FAQ
MindImmune Therapeutics, Inc. operates in the Biotechnology industries. More details can be found on the official website: mindimmune.com.
The headquarters of MindImmune Therapeutics, Inc. are located in Kingston, United States.
The current CEO of MindImmune Therapeutics, Inc. is Stevin Zorn
MindImmune Therapeutics, Inc. currently employs 1-10 people.
MindImmune Therapeutics, Inc.'s revenue is approximately < 1M.
